Specialty

Image description

FDA approves Genzyme MS treatment

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

Image description

UCB sells specialty generic wing for $1.5 billion

UCB, Advent International and Avista Capital Partners last week announced they have entered into a definitive agreement providing for the acquisition of UCB’s U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals, by Advent and Avista.

Image description

FDA grants approval to Obizur

he Food and Drug Administration last week announced approval for Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A.